CANNABINOID EPIGENOMIC AND MIRNA MECHAMISMS IMPACT HIV/SIV DISEASE PROGRESSION

大麻素表观基因组和 miRNA 机制影响 HIV/SIV 疾病进展

基本信息

  • 批准号:
    8358169
  • 负责人:
  • 金额:
    $ 5.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. 9-THC is the major psychoactive cannabinoid in marijuana. Advanced understanding of its pharmacology and the major cannabinoid receptor subtypes (CB1 and CB2) as well as their localization (CB2 predominantly on B lymphocytes and natural killer cells) has resulted in identification of multisystemic biomedical effects. Particularly important is the potential of 9-THC modulation of immune function in human immunodeficiency virus (HIV) infected individuals. Our studies indicate that chronic 9-THC treatment attenuates viral load and tissue inflammation in simian immunodeficiency virus (SIV) infected non-human primates, significantly decreasing morbidity and mortality from SIV infection. In addition, 9-THC decreased viral replication in an in vitro assay. While the ability of cannabinoids to suppress inflammation and viral replication has been reported by others and confirmed by our ongoing studies, the mechanisms involved are not known. Preliminary data obtained in preparation for this project revealed increased expression of a distinct miRNA profile associated with decreased immune activation and anti-inflammatory properties (based on predicted targets) in CD4+ T lymphocytes, intestinal mucosa, and brain of THC-treated SIV infected animals. These findings clearly suggest that the overall mechanisms mediating the protective effects of cannabinoids involve novel epigenomic regulatory factors/mechanisms in need of systematic investigation. The overall hypothesis of this proposal is that chronic 9-THC treatment decreases proinflammatory gene expression and viral replication through epigenomic (non-coding RNAs and DNA methylation) mechanisms. As a result, chronic cannabinoid treatment delays disease progression in SIV-infected non-human primates. Seven animals have been assigned (2 THC+ SIV+, 2 THC-/SIV+, 2 THC+/SIV-, 1 Vehicle only control) to the study for year 1 and the project is currently in progress.
这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的, 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量, 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 9-THC是大麻中主要的精神活性大麻素。对其药理学和主要大麻素受体亚型(CB 1和CB 2)及其定位(CB 2主要位于B淋巴细胞和自然杀伤细胞上)的深入了解已导致多系统生物医学效应的鉴定。特别重要的是9-THC调节人免疫缺陷病毒(HIV)感染个体的免疫功能的潜力。我们的研究表明,慢性9-THC治疗减弱猴免疫缺陷病毒(SIV)感染的非人灵长类动物的病毒载量和组织炎症,显著降低SIV感染的发病率和死亡率。此外,9-THC在体外测定中降低病毒复制。虽然大麻素抑制炎症和病毒复制的能力已经被其他人报道,并被我们正在进行的研究证实,但所涉及的机制尚不清楚。在为该项目做准备时获得的初步数据显示,在THC处理的SIV感染动物的CD 4 + T淋巴细胞、肠粘膜和脑中,与免疫激活和抗炎特性(基于预测的靶点)降低相关的独特miRNA谱的表达增加。这些发现清楚地表明,介导大麻素保护作用的总体机制涉及需要系统研究的新表观基因组调控因子/机制。该建议的总体假设是,慢性9-THC治疗通过表观基因组(非编码RNA和DNA甲基化)机制降低促炎基因表达和病毒复制。因此,慢性大麻素治疗延缓了SIV感染的非人灵长类动物的疾病进展。7只动物(2只THC+ SIV+、2只THC-/SIV+、2只THC+/SIV-、1只仅溶剂对照)已分配至第1年的研究,该项目目前正在进行中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mahesh Mohan其他文献

Mahesh Mohan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mahesh Mohan', 18)}}的其他基金

Cannabinoid modulation of EV composition and function in HIV/SIV infection
大麻素对 HIV/SIV 感染中 EV 组成和功能的调节
  • 批准号:
    10693315
  • 财政年份:
    2022
  • 资助金额:
    $ 5.78万
  • 项目类别:
Cannabinoid modulation of EV composition and function in HIV/SIV infection
大麻素对 HIV/SIV 感染中 EV 组成和功能的调节
  • 批准号:
    10662831
  • 财政年份:
    2022
  • 资助金额:
    $ 5.78万
  • 项目类别:
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
表征无膜冷凝物的物理化学性质及其在 HIV/SIV 感染中通过 delta-9-四氢大麻酚的调节。
  • 批准号:
    10664337
  • 财政年份:
    2021
  • 资助金额:
    $ 5.78万
  • 项目类别:
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
表征无膜冷凝物的物理化学性质及其在 HIV/SIV 感染中通过 delta-9-四氢大麻酚的调节。
  • 批准号:
    10842560
  • 财政年份:
    2021
  • 资助金额:
    $ 5.78万
  • 项目类别:
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
表征无膜冷凝物的物理化学性质及其在 HIV/SIV 感染中通过 delta-9-四氢大麻酚的调节。
  • 批准号:
    10220203
  • 财政年份:
    2021
  • 资助金额:
    $ 5.78万
  • 项目类别:
Role of microRNAs in B-cell dysfunction in HIV/SIV infection
microRNA 在 HIV/SIV 感染 B 细胞功能障碍中的作用
  • 批准号:
    10060222
  • 财政年份:
    2020
  • 资助金额:
    $ 5.78万
  • 项目类别:
Cannabinoid modulation of EV composition and function in HIV/SIV infection
大麻素对 HIV/SIV 感染中 EV 组成和功能的调节
  • 批准号:
    10220005
  • 财政年份:
    2019
  • 资助金额:
    $ 5.78万
  • 项目类别:
Cannabinoid modulation of EV composition and function in HIV/SIV infection
大麻素对 HIV/SIV 感染中 EV 组成和功能的调节
  • 批准号:
    10020177
  • 财政年份:
    2019
  • 资助金额:
    $ 5.78万
  • 项目类别:
Molecular pathology of oral immune dysregulation in HIV/SIV infection
HIV/SIV 感染口腔免疫失调的分子病理学
  • 批准号:
    10133355
  • 财政年份:
    2017
  • 资助金额:
    $ 5.78万
  • 项目类别:
Role of microRNAs in B-cell dysfunction in HIV/SIV infection
microRNA 在 HIV/SIV 感染 B 细胞功能障碍中的作用
  • 批准号:
    9141644
  • 财政年份:
    2016
  • 资助金额:
    $ 5.78万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 5.78万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 5.78万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 5.78万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 5.78万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了